Remedent Inc
Remedent, Inc. researches, designs, develops, manufactures, and distributes oral care and cosmetic dentistry products in the United States and internationally. It primarily provides professional veneers and teeth whitening products for professional and over-the-counter use. The company also offers River8, a prefab veneer that enables the dentist to find the right combination of teeth for a patien… Read more
Market Cap & Net Worth: Remedent Inc (REMI)
Remedent Inc (PINK:REMI) has a market capitalization of $477.10 ($477.10) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #45771 globally and #14344 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Remedent Inc's stock price $0.05 by its total outstanding shares 9542 (9.54K).
Remedent Inc Market Cap History: 2015 to 2025
Remedent Inc's market capitalization history from 2015 to 2025. Data shows change from $1.45K to $477.10 (-15.64% CAGR).
Remedent Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Remedent Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Remedent Inc's market cap is 0.00 times its annual revenue
169.90x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $1.45K | $3.62 Million | $105.16K | 0.00x | 0.01x |
| 2016 | $1.62K | $2.77 Million | $160.80K | 0.00x | 0.01x |
| 2017 | $3.24K | $2.36 Million | $844.37K | 0.00x | 0.00x |
| 2018 | $2.19K | $2.70 Million | -$54.59K | 0.00x | N/A |
| 2019 | $1.59K | $1.60 Million | $2.13 Million | 0.00x | 0.00x |
| 2020 | $1.43K | $1.06 Million | -$854.27K | 0.00x | N/A |
| 2021 | $1.62K | $1.03 Million | -$163.10K | 0.00x | N/A |
| 2022 | $1.62K | $1.41 Million | -$257.18K | 0.00x | N/A |
| 2023 | $954.20 | $863.82K | -$1.49 Million | 0.00x | N/A |
| 2024 | $477.10 | $986.22K | -$274.45K | 0.00x | N/A |
Competitor Companies of REMI by Market Capitalization
Companies near Remedent Inc in the global market cap rankings as of March 19, 2026.
Key companies related to Remedent Inc by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #98 globally with a market cap of $170.40 Billion USD.
- EssilorLuxottica Société anonyme (PINK:ESLOF): Ranked #263 globally with a market cap of $78.22 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #362 globally with a market cap of $61.18 Billion USD ( €59.61 Billion EUR).
- Becton Dickinson and Company (NYSE:BDX): Ranked #472 globally with a market cap of $45.90 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #98 | Intuitive Surgical Inc | NASDAQ:ISRG | $170.40 Billion | $482.76 |
| #263 | EssilorLuxottica Société anonyme | PINK:ESLOF | $78.22 Billion | $265.00 |
| #362 | EssilorLuxottica S. A. | PA:EL | $61.18 Billion | €203.00 |
| #472 | Becton Dickinson and Company | NYSE:BDX | $45.90 Billion | $161.64 |
Remedent Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, Remedent Inc's market cap moved from $1.45K to $ 477.10, with a yearly change of -15.64%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $477.10 | 0.00% |
| 2024 | $477.10 | -50.00% |
| 2023 | $954.20 | -41.18% |
| 2022 | $1.62K | 0.00% |
| 2021 | $1.62K | +13.33% |
| 2020 | $1.43K | -10.18% |
| 2019 | $1.59K | -27.39% |
| 2018 | $2.19K | -32.35% |
| 2017 | $3.24K | +100.00% |
| 2016 | $1.62K | +11.84% |
| 2015 | $1.45K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Remedent Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $477.10 USD |
| MoneyControl | $477.10 USD |
| MarketWatch | $477.10 USD |
| marketcap.company | $477.10 USD |
| Reuters | $477.10 USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.